Convertible Note - MPC Therapeutics
Investment Firm
Overview
MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.
Announced Date
Apr 01, 2019
Funding Type
Convertible Note
Highlights
Location
Switzerland, Europe
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Eclosion SA |
Round Details and Background
MPC Therapeutics raised $220143 on 2019-04-01 in Convertible Note
MPC Therapeutics develops a class of compounds with applications in immunotherapy and metabolic diseases.
Company Funding History
6
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 01, 2019 |  Grant - MPC Therapeutics | 1 | - | 658.3K |
| Nov 01, 2020 | Grant - MPC Therapeutics | - | 180.0K | |
| Jan 10, 2023 | Seed Round - MPC Therapeutics | 1 | - | 1.6M |
| Nov 16, 2023 | Debt Financing - MPC Therapeutics | 1 | - | 112.5K |
Recent Activity
There is no recent news or activity for this profile.